Exact Sciences Grants Inducement Restricted Stock Unit Awards to New Employees

Exact Sciences Corp. (NASDAQ: EXAS) today announced that, in support of the Company's continued growth plans, it has issued restricted stock units covering a total of 125,661 shares of common stock to 166 new non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The Company is making this announcement as required by NASDAQ rules.

About Exact Sciences

Exact Sciences Corp. (NASDAQ: EXAS) is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Cologuard is included in the colorectal cancer screening guidelines of the American Cancer Society and stool DNA is included in the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the company's website at www.exactsciences.com, follow us on Twitter @ExactSciences or find us on Facebook.